A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Abroad (travel likely)RecruitingPHASE3
Conditions
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
GC2402 Study Site 104, Rancho Mirage, California, United States
GC2402 Study Site 109, Coral Springs, Florida, United States
GC2402 Study Site 105, Miami, Florida, United States
GC2402 Study Site 103, Port Charlotte, Florida, United States
GC2402 Study Site 110, New York, New York, United States
GC2402 Study Site 111, Cordova, Tennessee, United States
GC2402 Study Site 106, Sherman, Texas, United States